Clinical Trials Logo

Clinical Trial Summary

This randomized, controlled trial (RCT) compares the efficacy and safety of Ahmed Glaucoma Valve (AGV) implantation alone, with 3 minutes MMC application or with a single layer coverage of amniotic membrane. Outcomes include intraocular eye pressure (IOP), postoperative glaucoma medication and complications. AGV implantation site will be superior or inferior based on indication and these groups will be randomized separately.


Clinical Trial Description

n/a


Study Design

Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00893490
Study type Interventional
Source hahid Beheshti University of Medical Sciences
Contact Shahin Yazdani, MD
Email shahinyazdani@yahoo.com
Status Recruiting
Phase Phase 1

See also
  Status Clinical Trial Phase
Recruiting NCT01128699 - Ahmed Valve Glaucoma Implant With Adjunctive Subconjunctival Bevacizumab in Refractory Glaucoma Phase 3
Completed NCT05521334 - MicroPulse Transscleral Laser Cyclophotocoagulation With the Zig Zag Mode in Glaucoma. N/A
Recruiting NCT00349414 - Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Phase 1/Phase 2
Recruiting NCT04921098 - CPC in Adult Refractory Glaucoma N/A
Completed NCT01404364 - Use of Intravitreal Triamcinolone and Retrobulbar Chlorpromazine as Alternatives to the Management of Painful Blind Eye N/A
Completed NCT00971061 - Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma Phase 3
Not yet recruiting NCT05230355 - Comparison Between Two Techniques of Subthreshold Diode Laser Cyclophotocoagulation in Refractory Glaucoma N/A
Completed NCT04303897 - Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma